Devang K. Sanghavi

Inhaled nitric oxide: Expanding indications beyond traditional boundaries

Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator that improves ventilation–perfusion matching with minimal effect on systemic blood pressure. Although the FDA approval is restricted to neonatal hypoxic respiratory failure associated with pulmonary hypertension, many clinicians now use iNO in adults with...